Ratos acquires remaining shares in TFS
Ratos has acquired the remaining shares (40%) in the subsidiary Trial Form Support International AB (TFS) from partner and founder Daniel Spasic for an equity value of approximately EUR 11m. After the acquisition, Ratos’s ownership share totals 100%.Ratos acquired 60% of TFS, an international service provider and a so-called contract research organization (CRO) that conducts clinical trials for pharmaceutical, biotechnology and medical device companies, from founder and owner Daniel Spasic in 2015. With the acquisition of the remaining 40%, Ratos now owns 100% of the company. The